Cargando…
The tumor suppressor CREBBP and the oncogene MYCN cooperate to induce malignant brain tumors in mice
The tumor suppressor and chromatin modifier cAMP response element-binding protein binding protein (CREBBP) and v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog (MYCN), a member of the MYC oncogene family, are critically involved in brain development. Both genes are frequentl...
Autores principales: | Schoof, Melanie, Epplen, Gefion Dorothea, Walter, Carolin, Ballast, Annika, Holdhof, Dörthe, Göbel, Carolin, Neyazi, Sina, Varghese, Julian, Albert, Thomas Karl, Kerl, Kornelius, Schüller, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322855/ https://www.ncbi.nlm.nih.gov/pubmed/37407554 http://dx.doi.org/10.1038/s41389-023-00481-3 |
Ejemplares similares
-
HGG-15. Generation of a novel mouse model for brain tumors of the DNA methylation class “GBM MYCN”
por: Schoof, Melanie, et al.
Publicado: (2022) -
BIOL-10. MOUSE MODELING OF PEDIATRIC MYCN GLIOMA REVEALS INTRATUMORAL HETEROGENEITY INCLUDING NEURONAL AND OLIGODENDROGLIAL LINEAGE SIGNATURES
por: Schoof, Melanie, et al.
Publicado: (2023) -
Simultaneous Brg1 Knockout and MYCN Overexpression in Cerebellar Granule Neuron Precursors Is Insufficient to Drive Tumor Formation but Temporarily Enhances their Proliferation and Delays their Migration
por: Holdhof, Dörthe, et al.
Publicado: (2021) -
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures
por: Schoof, Melanie, et al.
Publicado: (2023) -
Generation of new transgenic SMARCA4‐deficient mouse models results in neuromuscular weakness and paralysis of limbs
por: Neyazi, Sina, et al.
Publicado: (2022)